Role of the Methylenetetrahydrofolate Reductase (MTHFR) A1982C Gene Polymorphism in Predicting Clinical Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantationin Patients with Myeloid Leukemia

Role of 5,10-methylenetetrahydrofolate reductase (MTHFR) A1298G polymorphism in Methotrexate Pharmacodynamics, used as GVHD prophylaxis, in myeloid leukemic patients undergoing HSCT is still uncertain.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Essam El Beih, Raafat Abdel-Fattah, Hosam Kamel, Mohamed Samra, Alaa El-Haddad, Omar Fahmy, Gamal Fathy, Gamal Ebid, Eman Radwan, Azza Kamel Source Type: research